Clinical trials
Kidney Failure clinical trials
Below are recruiting kidney failure clinical trials, each written for real people, not researchers. We’re tracking 115 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07596043Recruiting
Higher protein for intensive care patients with kidney failure
This study compares giving a higher amount of protein to a standard amount in ICU patients with sudden kidney failure who need dialysis. The goal is to see if more protein helps recovery.
Bangkok, BangkokAges 18 years+ - NCT07442448Enrolling by invitationPhase 4
Study of Finerenone for heart and kidney health in diabetes
This trial tests a medication called Finerenone to see if it can improve heart structure and function in people with both diabetic kidney disease and heart failure. If you have type 2 diabetes, kidney problems, and heart failure with preserved pumping function, this study may explore a new treatment option for you.
TaipeiAges 18 years+ - NCT05944016RecruitingPhase 3
Dapagliflozin for early Alport kidney disease in teens and young adults
This trial tests dapagliflozin, a daily medicine, to slow kidney problems in people with early-stage chronic kidney disease caused by Alport syndrome. It may help protect kidney function and reduce worsening over time.
Heidelberg, Baden-WürttenbergAges 10–39 - NCT06635525Recruiting
How kidney failure affects your flu shot response
This study looks at how well the flu vaccine works in people with kidney failure who are on dialysis compared to healthy people. It will help doctors understand how kidney problems affect the body’s immune response to vaccination.
MilanAges 18–70 - NCT04626167RecruitingEarly Phase 1
Testing a bladder transplant done with a kidney transplant
This early-phase study is testing a combined bladder and kidney transplant approach for people whose bladder problems damage the kidneys. The goal is to see if this treatment can improve bladder and kidney outcomes and be done safely.
Rochester, MinnesotaAges 1–60 - NCT06642597Recruiting
Starting incremental peritoneal dialysis prescription
This trial tests a gradual approach to starting peritoneal dialysis (a type of dialysis done at home) for people who are new to dialysis. It aims to see if slowly increasing the dose is safe and helpful.
Blacktown, New South WalesAges 18 years+ - NCT01331668Recruiting
Kidney transplant biobank study for donors and recipients
This trial collects and stores health information and samples related to kidney transplants from both donors and recipients. It may help researchers better understand transplant outcomes and improve care in the future.
Leuven, BEAges Any age - NCT05562869RecruitingPhase 3
Belatacept instead of tacrolimus for early kidney graft problems
This trial looks at replacing standard anti-rejection medicines (tacrolimus, a type of CNI, plus mycophenolate and possibly prednisone) with belatacept in adults who have early kidney graft dysfunction 3–12 months after a kidney transplant. It aims to see if belatacept can control rejection and protect kidney function in the right patients.
Nantes, Loire AtlantiqueAges 18–99 - NCT07763418RecruitingPhase 1
Kidney function study of golcadomide
This study tests how a new drug, golcadomide, works in people with severe kidney problems compared to those with normal kidneys. It helps see if the drug needs different dosing for patients with kidney issues.
Chandler, ArizonaAges 18–84 - NCT07754331RecruitingPhase 1
Effect of hemodialysis on balcinrenone and dapagliflozin
This study is testing two investigational drugs, balcinrenone and dapagliflozin, in people with kidney failure who are on hemodialysis. The purpose is to see how your body processes these drugs when you are on dialysis, and to make sure they are safe.
Orlando, FloridaAges 18–80 - NCT07656168Recruiting
Testing a new blood filter to improve quality of life in kidney failure
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
BeijingAges 18 years+ - NCT06707532Recruiting
Muscle relaxants for safer heart rhythm treatment
This study tests if giving muscle relaxants before a heart ablation procedure can protect muscles from damage. Ablation uses energy to fix irregular heartbeats, and muscle relaxants might make it safer.
Wroclaw, Lower Silesian VoivodeshipAges 18–90 - NCT06917950RecruitingPhase 1/Phase 2
Roxadustat for bone and brain health in dialysis patients
This study tests whether roxadustat, a medicine for anemia, can also help with bone problems and mood or thinking issues in people on hemodialysis.
Al Mansurah, DakahliyaAges 18 years+ - NCT06903559RecruitingPhase 1/Phase 2
Roxadustat for heart and nutrition in dialysis patients
This study tests whether roxadustat can help improve heart health, nutrition, and reduce inflammation in people on hemodialysis. It may offer a new treatment option for anemia related to kidney disease.
Al Mansurah, DakahliyaAges 18 years+ - NCT07085728RecruitingPhase 2
Comparing two drug combinations for newly diagnosed multiple myeloma with kidney failure
This trial tests a new combination of drugs (daratumumab, bortezomib, and dexamethasone) against the usual combination (cyclophosphamide, bortezomib, and dexamethasone) in people with newly diagnosed multiple myeloma who also have kidney failure. The goal is to see if the new combination works better and helps protect kidney function.
Anchorage, AlaskaAges 18 years+ - NCT06659835Recruiting
Amino acid loss during kidney dialysis in the ICU
This study looks at how many amino acids (building blocks of protein) are lost during continuous kidney dialysis in patients in the intensive care unit after surgery. It may help doctors better understand how to support nutrition in these patients.
Vienna, State of ViennaAges 18 years+ - NCT06889948RecruitingPhase 2
Daratumumab for kidney disease caused by abnormal proteins
This trial tests if daratumumab can help people with a kidney condition called MGRS, where abnormal proteins damage the kidneys. The goal is to see if the drug can reduce protein in the urine and protect kidney function.
HelsinkiAges 18 years+ - NCT06487546Recruiting
Ergothioneine supplement study for dialysis patients
This study tests whether giving a natural antioxidant called ergothioneine can help people with kidney failure who are on dialysis. It aims to see if it improves their health or well-being.
Palo Alto, CaliforniaAges 18 years+ - NCT04932148Recruiting
Dialysis support study for people starting hemodialysis
This study tests whether an added dialysis plan can improve health outcomes for adults who are starting hemodialysis (a machine-based form of dialysis). It may help doctors find better ways to support people during their first year of dialysis care.
Concord, New South WalesAges 18 years+ - NCT04671771Recruiting
Testing a new graft for hemodialysis access in kidney failure
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
Phoenix, ArizonaAges 18–90 - NCT02699736Enrolling by invitation
HIV and hepatitis C study in European adults
This study follows people living with HIV who also have hepatitis C antibodies, to better understand how HIV and hepatitis C affect health over time. You may be able to join if you meet the age and enrollment requirements, even if your hepatitis C virus level is currently undetectable.
Buenos AiresAges 16 years+ - NCT01893710Recruiting
Collecting children and adult belly fluid and tissue for kidney care research
This study collects samples from the belly (related to the peritoneal lining) to build a “biobank” for future research. It may help patients and families by improving understanding of kidney disease and kidney dialysis-related health issues.
Birmingham, AlabamaAges 1 day–90 years - NCT06908746Recruiting
Citrate Anticoagulation in Dialysis for Liver and Kidney Failure
This trial looks at whether a blood thinner called citrate is safe and effective in patients who have both kidney and liver failure while on continuous dialysis in the ICU. It may help guide treatment for people with serious organ problems.
Edegem, AntwerpAges 18 years+ - NCT06987604Enrolling by invitation
Dialysis intensity for high ammonia in liver failure
This trial tests if a higher intensity of continuous dialysis (CRRT) better lowers ammonia levels in patients with liver failure. It aims to find the best approach to reduce brain complications from high ammonia.
Porto Alegre, Rio Grande do SulAges 18 years+
Hear when a new Kidney Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for kidney failure?
- Yes. Clin2 currently lists 115 recruiting kidney failure studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a kidney failure trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a kidney failure trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.